drugset / Trial / NCT03870529
High Dose Vitamin A Compound in Treating Participants With Resectable Non-Small Cell Lung Cancer
Phase 0
Terminated
20 enrolled
Wake Forest University Health Sciences
National Cancer Institute (NCI) · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
This trial studies how well high dose vitamin A compound works in treating participants with non-small cell lung cancer that can be removed by surgery. Vitamin A compound may increase the number of germinal centers (immune centers that make antibodies mature) in tumor and lymph tissues which may be beneficial to patients with cancer.
Timeline
- Start
- 2019-08-19
- Primary completion
- 2022-12-09
- Completion
- 2022-12-09
Outcome
Outcome not reported
Stopped (Enrollment): “Slow accruals”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vitamin A Compound | Unknown | — | Oral |